United States · Funded startup

Who invested in Amylyx Pharmaceuticals

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$175Mraised across 1 round since 2025, from 1 source

Latest round
Round, $175MSept 2025
Investors
4
See who backed them

The rounds

  1. Sept 2025

Founders and team

From Amylyx Pharmaceuticals's own website and the SEC filings it signed: 12 on the team.

  • Josh CohenCo-CEO of Amylyx
  • Justin KleeCo-CEO of Amylyx
  • Dan MonahanChief Commercial Officer
  • Gina M. MazzarielloChief Legal Officer & General Counsel
  • James M. FratesChief Financial Officer
  • Linda A. ArsenaultChief Human Resources Officer
  • Tom HolmesChief Technical Operations Officer
  • Daphne QuimiDirector
  • Kari FirestoneDirector
  • Paul FonteyneDirector
  • Joshua CohenExecutive Officer, Directori
  • Peter FinnExecutive Officeri

On the board, as filediFelix Von CoerperGeorge MilneIsaac ChengStephen ChubbWalter Gilbert

Everyone who backed them

Perceptive AdvisorsAsset manager1round
Alpha Wave GlobalPrivate equity1round
Viking GlobalVC firm1round
Bain Capital Life SciencesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Amylyx Pharmaceuticals

Who invested in Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals's investors include Perceptive Advisors, Alpha Wave Global, Viking Global and Bain Capital Life Sciences.

How much has Amylyx Pharmaceuticals raised?

Amylyx Pharmaceuticals has raised $175M across 1 round since 2025.

When did Amylyx Pharmaceuticals last raise?

Amylyx Pharmaceuticals's most recent round was an Undisclosed round of $175M in Sept 2025.

What was Amylyx Pharmaceuticals's biggest round?

Its most recent round, $175M in Sept 2025, is also its largest on record.

Who backed Amylyx Pharmaceuticals first?

Amylyx Pharmaceuticals's first round on record, in Sept 2025, was backed by Perceptive Advisors, Alpha Wave Global and Viking Global and 1 others.

What stage is Amylyx Pharmaceuticals at?

Amylyx Pharmaceuticals's latest named round is an Undisclosed round, in Sept 2025.

Where is Amylyx Pharmaceuticals based?

Amylyx Pharmaceuticals is based in the United States.

Companies like Amylyx Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.